Contact Us
Drug Search Results
More Filters [+]

Encenicline

Alternative Names: encenicline, evp-6124, mt-4666
Latest Update: 2024-05-06
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: nAChR Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: FORUM
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Encenicline

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Alzheimer Disease|Schizophrenia|Cognitive Dysfunction

Phase 2: Schizophrenia|Tobacco Use Disorder|Smoking Cessation|Alzheimer Disease

Phase 1: Schizophrenia|Affective Disorders, Psychotic|Psychotic Disorders|Kidney Diseases|Other|Alzheimer Disease|Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
EVP-6124-026

P3

Terminated

Alzheimer Disease

2017-08-01

EVP-6124-025

P3

Terminated

Alzheimer Disease

2017-01-01

EVP-6124-024

P3

Terminated

Alzheimer Disease

2017-01-01

EVP-6124-027

P2

Withdrawn

Alzheimer Disease

2016-10-01

Recent News Events

Date

Type

Title

05/06/2024

PubMed

 Advancements in Non-Dopaminergic Treatments for Schizophrenia: A Systematic Review of Pipeline Developments.

03/27/2024

PubMed

 Characterizing the binding of TC-5619 and encenicline on the alpha7 nicotinic acetylcholine receptor using PET imaging in the pig.

02/20/2024

PubMed

 Molecular Docking Analysis at the Human α7-nAChR and Proliferative and Evoked-Calcium Changes in SH-SY5Y Cells by Imidacloprid and Acetamiprid Insecticides.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions